Approval · Notice of Compliance 6727 · 2005
ULCIDINE: Notice of Compliance 6727
Issued May 13, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6727
- Date
- May 13, 2005
- Company
- Valeant Canada LpLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Histamine h2 receptor antagonist
Products in this notice
Medicinal ingredients
- FAMOTIDINE 20 MG per TAB
- FAMOTIDINE 40 MG per TAB